Healthcare & Life Sciences
Biograph 55
United Stateswww.biograph55.com
Biograph 55 is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Biograph 55
Biograph 55 is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Biograph 55 develops a bispecific antibody immunotherapy (B%%-001) that targets a unique regulatory B-cell population in solid tumors to potentially treat cancer patients unresponsive to checkpoint inhibitors, and is also developing therapies to eliminate plasma cells involved in autoimmune diseases.
Explore Biograph 55's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.